These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12599621)

  • 1. [Update of familial prostate cancer in Japan].
    Ohtake N; Nakata S; Fukabori Y; Suzuki K; Yamanaka H
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():469-73. PubMed ID: 12599621
    [No Abstract]   [Full Text] [Related]  

  • 2. Correspondence re: J.L. Stanford et al., Polymorphic receptor in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res., 57: 1194-1198, 1997.
    Yasui T
    Cancer Res; 2000 Jan; 60(2):499. PubMed ID: 10667606
    [No Abstract]   [Full Text] [Related]  

  • 3. The androgen receptor CAG repeat and prostate cancer risk.
    Clark PE; Irvine RA; Coetzee GA
    Methods Mol Med; 2003; 81():255-66. PubMed ID: 12725125
    [No Abstract]   [Full Text] [Related]  

  • 4. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
    Stanford JL; Just JJ; Gibbs M; Wicklund KG; Neal CL; Blumenstein BA; Ostrander EA
    Cancer Res; 1997 Mar; 57(6):1194-8. PubMed ID: 9067292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the AR and PSA genes as markers of susceptibility and aggressiveness in prostate cancer.
    Kuasne H; Rodrigues IS; Fuganti PE; Losi-Guembarovski R; Ito K; Kishima MO; Rodrigues MA; Rogatto SR; Santos RM; Cólus IM
    Cancer Invest; 2010 Nov; 28(9):917-24. PubMed ID: 20632874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor polymorphisms and the incidence of prostate cancer.
    Chen C; Lamharzi N; Weiss NS; Etzioni R; Dightman DA; Barnett M; DiTommaso D; Goodman G
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1033-40. PubMed ID: 12376504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer.
    Binnie MC; Alexander FE; Heald C; Habib FK
    Prostate; 2005 Jun; 63(4):309-15. PubMed ID: 15599941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk.
    Modugno F; Weissfeld JL; Trump DL; Zmuda JM; Shea P; Cauley JA; Ferrell RE
    Clin Cancer Res; 2001 Oct; 7(10):3092-6. PubMed ID: 11595700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphic repeats in the androgen receptor gene in high-risk sibships.
    Miller EA; Stanford JL; Hsu L; Noonan E; Ostrander EA
    Prostate; 2001 Aug; 48(3):200-5. PubMed ID: 11494335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor CAG polymorphism and prostate cancer risk.
    Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
    Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer].
    Liu JH; Li HW; Tong M; Li M; Na YQ
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):364-8. PubMed ID: 15061984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?
    Zeegers MP; Kiemeney LA; Nieder AM; Ostrer H
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1765-71. PubMed ID: 15533905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk.
    Gsur A; Preyer M; Haidinger G; Schatzl G; Madersbacher S; Marberger M; Vutuc C; Micksche M
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):497-8. PubMed ID: 12010866
    [No Abstract]   [Full Text] [Related]  

  • 15. Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene.
    Li C; Grönberg H; Matsuyama H; Weber G; Nordenskjöld M; Naito K; Bergh A; Bergerheim U; Damber JE; Larsson C; Ekman P
    Int J Mol Med; 2003 Apr; 11(4):529-33. PubMed ID: 12632109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New biomarkers for prostate cancer].
    Suzuki H; Shimbo M; Ichikawa T
    Nihon Rinsho; 2005 Feb; 63(2):351-9. PubMed ID: 15714991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the androgen receptor CAG repeat length significant for prostate cancer?
    Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):985-6. PubMed ID: 12376496
    [No Abstract]   [Full Text] [Related]  

  • 18. Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer.
    Das K; Cheah PY; Lim PL; Zain YB; Stephanie FC; Zhao Y; Cheng C; Lau W
    Cancer Lett; 2008 Sep; 268(2):340-7. PubMed ID: 18495332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population.
    Patiño-García B; Arroyo C; Rangel-Villalobos H; Soto-Vega E; Velarde-Félix JS; Gabilondo F; Sandoval-Ramirez L; Figuera LE
    Rev Invest Clin; 2007; 59(1):25-31. PubMed ID: 17569297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
    Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
    Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.